FOSCHI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 6.762
AS - Asia 3.577
EU - Europa 2.666
SA - Sud America 844
Continente sconosciuto - Info sul continente non disponibili 196
AF - Africa 111
OC - Oceania 6
Totale 14.162
Nazione #
US - Stati Uniti d'America 6.509
SG - Singapore 1.380
IT - Italia 914
RU - Federazione Russa 725
BR - Brasile 671
CN - Cina 520
HK - Hong Kong 442
VN - Vietnam 441
BD - Bangladesh 396
DE - Germania 191
FR - Francia 183
FI - Finlandia 148
CA - Canada 141
NL - Olanda 137
IN - India 109
GB - Regno Unito 100
MX - Messico 68
AR - Argentina 66
AT - Austria 48
ES - Italia 40
EC - Ecuador 38
ID - Indonesia 37
JP - Giappone 35
PL - Polonia 35
ZA - Sudafrica 34
IQ - Iraq 33
SE - Svezia 30
IE - Irlanda 23
CL - Cile 20
CO - Colombia 20
TR - Turchia 19
ET - Etiopia 18
AE - Emirati Arabi Uniti 17
IR - Iran 17
MY - Malesia 16
UZ - Uzbekistan 16
PK - Pakistan 15
SA - Arabia Saudita 14
TH - Thailandia 14
PY - Paraguay 13
UA - Ucraina 13
DZ - Algeria 11
LT - Lituania 11
CR - Costa Rica 10
MA - Marocco 10
KZ - Kazakistan 9
TN - Tunisia 9
CH - Svizzera 8
VE - Venezuela 8
JM - Giamaica 7
RO - Romania 7
EG - Egitto 6
HU - Ungheria 6
IL - Israele 6
NP - Nepal 6
AU - Australia 5
AZ - Azerbaigian 5
BE - Belgio 5
CZ - Repubblica Ceca 5
GT - Guatemala 5
HN - Honduras 5
KR - Corea 5
PH - Filippine 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
PE - Perù 4
RS - Serbia 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
AL - Albania 3
AO - Angola 3
CG - Congo 3
GR - Grecia 3
KE - Kenya 3
PS - Palestinian Territory 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
AF - Afghanistan, Repubblica islamica di 2
BO - Bolivia 2
DK - Danimarca 2
DM - Dominica 2
GA - Gabon 2
GD - Grenada 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
BZ - Belize 1
EE - Estonia 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
Totale 13.950
Città #
Dallas 2.346
San Jose 765
Singapore 761
Ashburn 498
Hong Kong 432
Council Bluffs 410
Santa Clara 290
New York 175
Los Angeles 162
Boardman 159
Ho Chi Minh City 145
The Dalles 128
Moscow 123
Lauterbourg 113
Hanoi 107
Beijing 95
Milan 91
Lappeenranta 83
Hefei 78
São Paulo 67
Rome 63
Orem 57
Munich 52
Montreal 46
Toronto 44
Frankfurt am Main 38
Mexico City 37
Verona 37
Denver 36
Phoenix 36
Helsinki 34
L’Aquila 32
Warsaw 28
Chicago 27
Da Nang 27
Rio de Janeiro 26
Buffalo 25
Turku 25
Atlanta 23
Brooklyn 23
Naples 23
Shanghai 23
Stockholm 23
London 22
San Francisco 22
West Jordan 22
Chennai 21
Tokyo 21
Turin 21
Bologna 20
Haiphong 20
Curitiba 19
Seattle 19
Benevento 18
Dublin 18
Düsseldorf 18
Mumbai 18
Amsterdam 17
Charlotte 17
Guayaquil 17
Nuremberg 17
Piscataway 17
Boston 16
Johannesburg 15
Poplar 15
Tashkent 15
Ankara 14
Vienna 14
Houston 13
Brasília 12
Florence 12
City of London 11
Kitzingen 11
Manchester 11
Spoltore 11
St Louis 11
Chandler 10
Falkenstein 10
Ha Long 10
Jakarta 10
Palermo 10
Pescara 10
Taizhou 10
Baghdad 9
Bari 9
Belo Horizonte 9
Campinas 9
Hải Dương 9
Madrid 9
New Delhi 9
Salvador 9
San José 9
Santiago 9
Addis Ababa 8
Assago 8
Kuala Lumpur 8
Miami 8
Quito 8
Ribeirão Preto 8
Thái Bình 8
Totale 8.574
Nome #
Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis 380
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 359
Do antithrombotic drugs have a role in migraine prevention? A systematic review 358
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis 354
Coronary Artery Disease and Atherosclerosis in Other Vascular Districts: Epidemiology, Risk Factors and Atherosclerotic Plaque Features 297
Implementing Blood Biomarkers in Stroke Research and Clinical Practice 291
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 285
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years 281
Persistent progression independent of relapse activity in multiple sclerosis 222
High-Density Lipoprotein Cholesterol Levels and their impact on outcomes in acute ischemic stroke patients treated with mechanical thrombectomy 213
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage 172
Age‐Specific Differences in Inflammatory Biomarkers and Their Impact on Futile Recanalization After Mechanical Thrombectomy: An Inverse Probability Weighting Analysis 170
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 169
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 167
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 160
Point-Of-Care low-field MRI in acute Stroke (POCS): protocol for a multicentric prospective open-label study evaluating diagnostic accuracy 160
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 158
C-Reactive Protein elevation and subsequent atrial fibrillation detection after ischemic stroke treated with mechanical thrombectomy: an inverse probability weighting analysis 156
Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke 150
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023 148
Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 146
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 143
Outcomes of Mechanical Thrombectomy in Patients With Ischemic Stroke and Heart Failure. A Systematic Review and Meta‐analysis 139
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis 138
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 132
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 129
Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 127
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study 125
How far are we from bringing intensive care bundle for intracerebral hemorrhage into the real-world setting? A 5-year population based-study 119
Acute stroke-like deficits associated with nonketotic hyperglycemic hyperosmolar state: an illustrative case and systematic review of literature 112
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 109
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 109
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 108
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 101
Sex-based differences in inflammatory predictors of outcomes in patients undergoing mechanical thrombectomy: an inverse probability weighting analysis 101
Identifying Cladribine prescription pattern in MS: an Italian multicentre study 100
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 100
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 97
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 96
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 95
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024) 94
Enhancing stroke risk prediction in patients with transient ischemic attack: insights from a prospective cohort study implementing fast-track care 92
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 92
Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021 91
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 91
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 90
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 89
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023 89
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 88
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study 85
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 85
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 84
The Italian Multiple Sclerosis Register Experience With Cladribine 83
Oral anticoagulation versus no anticoagulation for stroke prevention in patients with intracranial haemorrhage and atrial fibrillation: an updated meta-analysis of randomised controlled trials 83
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies 83
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study 83
Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10 years in a population-based stroke registry 81
Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine 80
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 80
Impact of Sex on Clinical Outcomes of Tandem Occlusion in Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy. A Propensity‐Matched Analysis 80
The impact of inflammatory markers on clinical outcomes in acute ischemic stroke patients following mechanical thrombectomy: A multicentre study 79
Clinical characteristics and outcomes of ischemic stroke despite appropriate oral anticoagulation for atrial fibrillation: A systematic review and meta-analysis of real-world studies 79
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability 78
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries 78
Switch from fingolimod to ozanimod for safety or intolerance reasons 77
Predictors of futile recanalization after intravenous thrombolysis in stroke patients transferred for endovascular treatment 76
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis 74
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities 74
Sleep-related disorders and their relationship with MRI findings in multiple sclerosis 73
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 72
Neurological abnormalities in individuals with Marfan syndrome: results from a genetically confirmed Italian cohort 72
Neurofilament light chain and glial fibrillary acidic protein as diagnostic and prognostic biomarkers in epileptic seizures and epilepsy: A systematic review 72
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 71
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 71
Antithrombotic treatment of cervical arterial dissection: Big data needed to inform long-term management 71
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis 71
Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study 68
Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31 68
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 68
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 67
Safety and Outcomes of Mechanical Thrombectomy in Acute Ischemic Stroke Attributable to Cardiological Diseases: A Scoping Review 66
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 66
A call for academic pragmatic clinical trials to address open questions in migraine prevention 65
Outcomes of different anesthesia techniques in nonagenarians treated with mechanical thrombectomy for anterior circulation large vessel occlusion: An inverse probability weighting analysis 65
Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort 64
Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020 64
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study 64
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 63
Annual level changes of serum neuronal and glial biomarkers in a German professional football club 63
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 62
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease 61
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 60
Blood GFAP as an emerging biomarker in brain and spinal cord disorders 59
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 59
“NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab” 58
Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020 58
Impact of Atrial Fibrillation on Outcomes in Stroke Patients with Tandem Occlusions Treated with Thrombectomy.A multicentre study 58
Stress hyperglycemia is associated with futile recanalization in patients with anterior large vessel occlusion undergoing mechanical thrombectomy 58
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry 58
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 57
Totale 11.386
Categoria #
all - tutte 52.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 0 7 1 3
2022/202390 1 2 0 3 3 4 0 2 12 1 5 57
2023/2024391 6 10 16 47 22 47 3 3 3 85 63 86
2024/20252.742 106 28 195 99 229 178 292 205 629 259 264 258
2025/20269.693 277 2.307 793 1.073 564 341 1.066 464 754 772 732 550
2026/20271.235 598 637 0 0 0 0 0 0 0 0 0 0
Totale 14.162